Ibrutinib in treatment for refractory or relapsed CLL
Venetoclax in combination with low-dose cytarabine – a promising regimen for the treatment of AML
Looking beyond the leukemic cell for answers
Christopher Pepper et al.
The combination of BGB-3111 and obinutuzumab for follicular lymphoma: promising preliminary results
T-SPOT assay for tuberculosis and cytomegalovirus - benefits, results and next steps